Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
Submitted by
admin
on August 24, 2017 - 11:25am
Source:
Fierce Pharma
News Tags:
AstraZeneca
Brilinta
blood thinners
Headline:
With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
Do Not Allow Advertisers to Use My Personal information
